WHO ICTRP trial
Donor milk for improved neurodevelopmental outcomes
ISRCTN35317141 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN35317141 |
|---|---|
| Public title | Donor milk for improved neurodevelopmental outcomes |
| Scientific title | Donor human milk versus preterm formula as a substitute for mothers' own milk for feeding very low birth weight infants |
| Primary sponsor | The Hospital for Sick Children |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Canada |
| Conditions | Neurodevelopmental outcomes Neonatal Diseases Neurodevelopmental outcomes |
| Interventions | Treatment Group: Infants randomised to the intervention group will receive donor milk when mothers' own milk is unavailable. Infants will continue to receive donor milk after transfer to a participating Level II NICU for 90 days after… |
| Registration date | Oct 8, 2010 |
| Target size | 352 |
| Secondary IDs | NCT02759809;MP-102638 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: